頁籤選單縮合
題 名 | 癌症化學治療支持性照護的新進展=Recent Advance of Supportive Care for Cancer Chemotherapy |
---|---|
作 者 | 王正旭; | 書刊名 | 腫瘤護理雜誌 |
卷 期 | 2:2 2002.12[民91.12] |
頁 次 | 頁61-69 |
分類號 | 419.77 |
關鍵詞 | 癌症化學治療; 支持性療法; Cancer chemotherapy; Supportive care; |
語 文 | 中文(Chinese) |
中文摘要 | 化學藥物治療是治療癌症重要的方式,隨著各類抗癌藥物的研發和臨床的應用,大部分癌症病情可以得到有效控制。近年來,積極而強效的化療應用於白血病、淋巴癌和其他化學藥物極具療效的癌病之後,治癒率明顯提高。相對的,其衍生的嚴重副作用如骨髓功能抑制、嘔吐和各種病菌的感染等,也讓病患面臨致命性的危險和極惡劣的生活品質。幸運的是,很多支持性的照護也有良好的進展,包括血管通路導管(人工靜脈植入器)廣泛使用,新型止吐劑的開發,骨髓功能的重建,血球生成激素的應用,和白血球嚴重不足時的臨床照護等。這些進展讓癌症病人在接受化學治療時有較好的生活品質,生命也更有保障。 |
英文摘要 | Treatment by using chemotherapeutic agents is an important modality for cancer therapy. In the last three decades, on the progress of new drugs development, the major primary symptoms of malignancy could be effectively controlled. High dose chemotherapy could even achieve higher cure rate in hematological malignancies including leukemia and lymphoma and some very chemo-sensitive solid tumors. In the mean time, high dose chemotherapy brings patients devastated complications e.g. bone narrow suppression, severe nausea/vomiting, and infections with a variety of microorganisms, which could be life threatening and/or compromise patient's quality of life. Fortunately, the creation of supportive care systems including application of vascular access for drug infusion, usage of 5-hydroxytryptamine receptor (5-HT3 receptor) antagonists for anti-emesis, bone marrow reconstruction and clinical care for febrile neutropenia helps patients keeping in better quality of life and protects them from mortality during chemotherapy. |
本系統中英文摘要資訊取自各篇刊載內容。